Global preventive policies. Strategies at European and worldwide level;Políticas preventivas globales. Estrategias a escala europea y mundial

Revista Espanola de Cardiologia

Volumn 61, Issue 9, 2008, Pages 960-970

  Kotseva, Kornelia ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Guidelines; Preventive policies; SCORE

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LIPID;

BLOOD PRESSURE REGULATION; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONSENSUS; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DEVELOPING COUNTRY; ENVIRONMENTAL FACTOR; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; LIPID BLOOD LEVEL; MANAGEMENT; ORGANIZATION; PRACTICE GUIDELINE; REVIEW; RISK FACTOR;

EID: 51949107687     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13125518     Document Type: Article

References (40)

1. World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. Geneva: WHO Library; 2007.
2. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14 Suppl 2:S1-113.
3. Allender S, Scharbotough P, Peto V, Rayner M, Leal J, Luengo-Fernández R, et al. European Cardiovascular disease statistics: 2008 edition. London: British Heart Foundation; 2008.
4. Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 2006;27:1610-9.
5. Lopez A, Mathers CD, Ezzati M, Jamison D, Murray C. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-57.
6. Preventing chronic disease: a vital investment. Geneva: World Health Organization; 2005.
7. World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: WHO Library; 2002.
8. Manuel DG, Lim J, Tanuseputro P, Anderson GM, Alter DA, Laupacis A, et al. Revisiting Rose: strategies for reducing coronary heart disease. BMJ. 2006;332:659-62.
9. World Health Organization. Prevention of recurrent heart attacks and strokes in low and middle income populations. Evidence-based recommendations for policy makers and health professionals. Geneva: WHO; 2003.
10. Global strategy for the prevention and control of noncommunicable diseases. Report by the Director General (Document A53/14). Geneva: World Health Organization; 2000.
11. Leeder S. A race against time: the challenge of cardiovascular disease in developing economies. New York: The Center for Global Health and Economic Development; 2004.
12. Secondary prevention of non-communicable diseases in low- and middle-income countries through community-based and health service interventions. Report of the Cambridge Meeting. World Health Organization and Welcome Trust, 2001.
13. Cardiovascular disease prevention. Translating evidence into action. Geneva: World Health Organization; 2005.
14. World Health Organization. CVD risk management package for low-and medium-resource settings. Geneva: WHO; 2002.
15. Smith SC Jr, Jackson R, Pearson TA, Fuster V, Yusuf S, Faergeman O, et al. Principles for national and regional guidelines on cardiovascular disease prevention: A scientific statement from the World Heart and Stroke Forum. Circulation. 2004;109:3112-21.
16. Integrated Management of Cardiovascular Risk: Report of a WHO Meeting. July 2002. Geneva: WHO Library; 2002.
17. WHO Framework Convention on Tobacco Control. Geneva: World Health Organization; 2003.
18. World Health Assembly Resolution WHA57.17. Global strategy on diet, physical activity and health. Geneva: World Health Organization; 2004.
19. Prevention of coronary heart disease. Report of a WHO Expert Committee. WHO Technical Report Series 678. Geneva: WHO; 1992.
20. Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14:32-8.
21. Rose G. The strategy of preventive medicine. Oxford: Oxford University Press; 1992.
22. World Health Organization. Reduction of cardiovascular burden through cost-effective integrated management of cardiovascular risk: addressing hypertension, smoking cessation and diabetes (NMH meeting report, 9-12 July 2002). Geneva: World Health Organization; 2002.
23. The Victoria Declaration: On Heart Health. En: Declaration of the Advisory Board of the International Heart Health Conference. Victoria, British Columbia, Canadá; 1992.
24. The Catalonia Declaration: Investing in Heart Health. En: Declaration of the Advisory Board of the Second International Heart Health Conference. Barcelona, España, 1996.
25. Pearson T, Bales VS, Blair L. The Singapore Declaration: forging the will for heart health in the next millennium. CVD Prevention. 1998;1:182-99.
26. The Osaka Declaration: Health, Economics and Political Action: Stemming the Tide of Cardiovascular Disease. En: Declaration of the Fourth International Heart Health Conference. Osaka, Japón; 2001.
27. Disponible en: http://ec.europa.eu/health/ph_determinants/ life_style/nutrition/documents/nutrition_gp_en.pdf
28. Disponible en: http://www.ptkardio.pl/files//file/ luxembourgdeclarationfinal.pdf
29. Disponible en: http://www.heartcharter.eu
30. Jackson R, Barham P, Bills J, Birch T, McLennan L, MacMahon S,et al. Management of raised blood pressure in New Zealand: a discussion document. BMJ. 1993;307:107-10.
31. Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ. 2000;320:709-10.
32. Pyörälä K, De Backer G, Graham I, Poole-Wilson PA, Wood D. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerotic Society and European Society of Hypertension. Eur Heart J. 1994;15:1300-31.
33. Wood D, De Backer G, Faergeman O, Graham I, Mancia G. Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J. 1998;19:1434-503.
34. Wood D, Durrington P, Poulter N, McInnes G, Rees A, Wray R; on behalf of the British Cardiac Society, British Hyperlipidaemia Assocoation, British Hypertension Society and British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart. 1998;80 Suppl 2:S1-29.
35. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association. JBS 2: Joint British Societies' Guidelines on Prevention of Cardiovascular Disease in Clinical Practice. Heart. 2005;91 Suppl V:1-52.
36. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
37. De Backer G, Ambrosioni E, Borch-Johnsen K. European guidelines on cardiovascular disease prevention in clinical practice. Executive Summary. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prevention Rehabilitation. 2003;10 Suppl 1:2-78.
38. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-8.
39. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:356-62.
40. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003.